Adam J. Esbenshade, MD, MSCI

Vanderbilt Children’s Hospital and Vanderbilt University Medical Center – John N. Lukens, Jr. Chair in Pediatric Hematology and Oncology; Professor of Pediatrics Hematology/Oncology

Dr. Esbenshade is a Pediatric Neuro-oncologist and Professor of Pediatrics. His research focuses on Cancer Control, Supportive Care, Central Nervous System Malignancy, and Cancer Survivorship. Areas of active investigation include risk prediction modeling and establishing evidence-based data for the treatment of infectious disease complications during pediatric cancer for which he has a current multi-institution prospective validation study. He is also working on studies to improve the treatment of obesity and metabolic syndrome in cancer survivors, validating a comprehensive risk score that summarizes a cancer survivor’s co-morbidities, as well as, clinical trials that focus on targeted therapy for CNS tumors. Dr. Esbenshade is a member of the Children’s Oncology Group (COG) and is the Vice Chair of the COG Young Investigators Committee and Vice Chair of the COG Cancer Control and Supportive Care Committee.

Dr. Esbenshade earned his medical degree from the University of Tennessee at Memphis, followed by an internship and residency in pediatrics at LeBonheur Children’s Hospital. He then earned a Master of Science in Clinical Investigation and completed a fellowship in pediatrics hematology/oncology at Vanderbilt University.